Raymond James & Associates Has $43.34 Million Position in Stericycle, Inc. (NASDAQ:SRCL)

Raymond James & Associates lowered its stake in shares of Stericycle, Inc. (NASDAQ:SRCLFree Report) by 4.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 874,410 shares of the business services provider’s stock after selling 40,043 shares during the quarter. Raymond James & Associates owned about 0.95% of Stericycle worth $43,336,000 at the end of the most recent reporting period.

Other large investors have also recently modified their holdings of the company. Raymond James Trust N.A. increased its stake in shares of Stericycle by 1.9% in the 4th quarter. Raymond James Trust N.A. now owns 27,464 shares of the business services provider’s stock valued at $1,361,000 after purchasing an additional 522 shares during the last quarter. Teachers Retirement System of The State of Kentucky lifted its holdings in shares of Stericycle by 93.3% in the third quarter. Teachers Retirement System of The State of Kentucky now owns 31,528 shares of the business services provider’s stock worth $1,410,000 after acquiring an additional 15,219 shares during the last quarter. Citigroup Inc. lifted its holdings in shares of Stericycle by 0.6% in the third quarter. Citigroup Inc. now owns 46,953 shares of the business services provider’s stock worth $2,099,000 after acquiring an additional 285 shares during the last quarter. SkyView Investment Advisors LLC lifted its holdings in shares of Stericycle by 4.5% in the third quarter. SkyView Investment Advisors LLC now owns 12,862 shares of the business services provider’s stock worth $575,000 after acquiring an additional 554 shares during the last quarter. Finally, Morgan Stanley lifted its holdings in shares of Stericycle by 10.4% in the third quarter. Morgan Stanley now owns 646,504 shares of the business services provider’s stock worth $28,905,000 after acquiring an additional 60,954 shares during the last quarter. Institutional investors and hedge funds own 98.82% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have recently commented on SRCL. StockNews.com cut shares of Stericycle from a “buy” rating to a “hold” rating in a report on Friday, March 22nd. Royal Bank of Canada reissued an “outperform” rating and issued a $69.00 target price on shares of Stericycle in a report on Thursday, March 7th. Truist Financial upped their price objective on Stericycle from $50.00 to $57.00 and gave the company a “hold” rating in a research note on Thursday, February 29th. Stifel Nicolaus upped their price objective on Stericycle from $70.00 to $75.00 and gave the company a “buy” rating in a research note on Thursday, February 29th. Finally, Wells Fargo & Company upped their price objective on Stericycle from $40.00 to $48.00 and gave the company an “underweight” rating in a research note on Friday, March 1st. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $62.25.

Get Our Latest Report on SRCL

Stericycle Stock Performance

Stericycle stock opened at $52.75 on Friday. The business has a 50 day moving average of $50.81 and a 200-day moving average of $47.34. Stericycle, Inc. has a 1 year low of $37.78 and a 1 year high of $57.06. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.94 and a quick ratio of 0.94. The company has a market capitalization of $4.88 billion, a P/E ratio of -219.78, a P/E/G ratio of 2.85 and a beta of 1.11.

Stericycle (NASDAQ:SRCLGet Free Report) last released its earnings results on Wednesday, February 28th. The business services provider reported $0.54 earnings per share for the quarter, beating analysts’ consensus estimates of $0.47 by $0.07. The business had revenue of $652.00 million during the quarter, compared to the consensus estimate of $657.99 million. Stericycle had a negative net margin of 0.80% and a positive return on equity of 7.06%. The company’s revenue for the quarter was down 2.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.60 EPS. On average, equities research analysts predict that Stericycle, Inc. will post 2.31 earnings per share for the current year.

Stericycle Company Profile

(Free Report)

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.

Featured Articles

Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle, Inc. (NASDAQ:SRCLFree Report).

Institutional Ownership by Quarter for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.